Objectives: To determine the impact of viral lower respiratory tract infections (LRTIs) in infancy including rhinovirus (RV) and infancy respiratory syncytial virus (RSV), on school age pulmonary function and healthcare utilization in prematurely born children.
| INTRODUCTION
Chronic respiratory morbidity is common in prematurely born infants.
The aetiology of that respiratory morbidity is multifactorial and includes respiratory syncytial virus (RSV) lower respiratory tract infections (LRTIs). Prematurely born infants are functionally 1, 2 and genetically 3 predisposed to RSV LRTIs and have worse lung function in infancy after the LRTI. 4, 5 Very prematurely born infants who had bronchopulmonary
| Assessment of pulmonary function
All pulmonary function testing was performed by the same operator (VMacB). Spirometry was conducted in accordance with ATS/ERS criteria 10 using a Jaeger Masterscreen device. Forced vital capacity (FVC), forced expiratory volume in one second (FEV 1 ) and FEV 1 /FVC ratio were measured and expressed as standardized residuals (z scores) relative to published predicted values taking into account sex, age and height. 11 Impulse oscillometry was conducted (Jaeger Masterscreen IOS) in accordance with published guidelines, 12 with the mean values for respiratory system resistance at 5 Hz (R5) and 20 Hz (R20) from three reproducible measurements reported and expressed as z scores relative to published predicted values. 13 The parasternal intercostal electromyogram was recorded from the second intercostal space during ten minutes of tidal breathing as per our previous work. 14 Full methodological details are given in the online supplementary material. EMGpara was log-transformed and expressed relative to predicted based on previously published data. 14 On the day of testing, pulmonary function and EMGpara were measured twice, once at baseline and then repeated twenty minutes after administration of 400 μg salbutamol via a metered-dose inhaler and spacer device.
| Healthcare utilization and health related cost of care
Participants' General Practitioners (GP) records were inspected to identify any hospital admissions, emergency department visits, hospital outpatient appointments, other contacts with health professionals, GP attendances, and all medication prescriptions. All visits for routine immunizations or health screening were not included in the analysis as these were deemed usual care for children. GP and hospital costs were calculated using the National Health Service (NHS) reference costing scheme 15 and medication costs using the NHS indicative costs listed within the British National Formulary. 16 Each healthcare contact or prescription was defined as respiratory-related or non-respiratory related through examination of clinical records to determine the primary reason for presentation.
Non-respiratory costs included both childhood illnesses and injuries (such as gastrointestinal conditions and fractures) and a small number of children with complex conditions requiring extensive input from multiple clinical specialties. Respiratory medications were antibiotics taken for respiratory disorders, preventers, and treatment for asthma. All other medications were classified as non-respiratory.
All healthcare costs were divided by the number of years of follow-up and expressed as UK pounds (£) per year for medication costs, hospital costs (inpatient stays, outpatient appointments, and emergency department visits) and overall health related costs of care, with GP attendances expressed as number of visits per year.
Healthcare utilization and health related cost of care were not reported for the first year after birth as these were previously reported. 
| Analysis
Comparisons were made between those children who did not have an LRTI (no LRTI group) and the virus groups (RSV, RV, or other virus). 
| RESULTS
Fifty-one children were recruited; healthcare utilization data only were available from four children due to geographical distance precluding attendance for full testing. A flow chart detailing reasons for nonparticipation is included within the online supplementary material. The characteristics of the children included did not differ significantly from those that did not with regard to birth weight, gestational age at birth, sex, duration of mechanical ventilation at birth or the proportion who were very low birth weight (birth weight < 1500 g). There were, however, significantly greater proportions of extremely low birth weight babies (birth weight < 1000 g, P = 0.006) and those who had had BPD (oxygen dependency at 28 days, P = 0.006) in those included in the current study (Table 1 ).
Compared to the no LRTI group, at the time of study, the RV group was older (P = 0.018) and the median BMI of the 'other LRTI' group was higher (P = 0.035), though with all values remaining within normal limits. The across-group comparison demonstrated a significant difference in birth weights, but this did not reach statistical significance on post hoc testing. There were no other significant differences between the groups (Table 2) .
Several children within each virus group had experienced multiple viral LRTIs or viral co-infections (Table 3) . Three children within the RSV group required hospital admission, one of whom had two admissions. There were no admissions in the RV or other LRTI groups.
Within the 14 children with RV LRTI, five had experienced RV type C, one type B, two type A, and in six infants the subtype was not identified. Data are presented as median (IQR) or n (%).
| Pulmonary function
Spirometry, IOS and EMGpara assessments were attempted in all of the 47 children attending for pulmonary function testing. It was possible to assess more children with EMGpara than the other two techniques. Spirometry was successfully undertaken in 33 (70%) children, IOS in 39 (83%) and EMGpara in 43 (91%) (P = 0.028).
FEV 1 and FVC differed significantly across the virus groups (Table 4 ). Compared to the no LRTI group, the RV group had a lower median FEV 1 (P = 0.033) and the other LRTI group a lower median FVC (P = 0.009). There were no other significant differences in lung function between the groups.
| Health related cost of care
Overall respiratory-related healthcare costs and respiratory-related GP attendances were higher in the other LRTI group (P = 0.042 and p = 0.012 respectively). The overall respiratory related healthcare costs did not differ significantly between the RV, RSV and the no LRTI group. Non-respiratory medication costs were significantly higher in both the RV (P = 0.018) and RSV (P = 0.013) groups (Table 5 ). A range of tests were used to assess respiratory function, as we felt that the use of non-volitional tests of pulmonary function would be advantageous in the assessment of a population known to exhibit higher rates of motor and cognitive impairments. There was a significant difference in the success of the children being able to perform three tests, with spirometry being the least successfully accomplished and EMGpara being the most successfully accomplished. Indeed, only 70% of the children, despite the majority being born moderately prematurely, were able to perform spirometry at school age. The EMGpara results, however, did not differ significantly between the three groups. It is possible that EMGpara, which is measured during tidal breathing, may be less sensitive to small deficits in pulmonary function that are apparent during the forced manoeuvres required of spirometry.
| DISCUSSION
Furthermore, the reference data are more limited for this technique due to its novelty and, therefore, subtle abnormalities may not be detected.
The median gestational age at birth of the children was 34 weeks indicating that the majority had been born moderately prematurely.
Such subjects, do, however, suffer morbidity following RSV infections. A systematic review demonstrated amongst infants born between 29 and 35 weeks the rates of RSV hospitalization varied from 2.3 to 10% and recurrent wheezing rates ranged from 20.7% to 42.8% one to 2 years after RSV hospitalization. 24 Other studies have shown consistently higher healthcare costs in the first year after birth in those infants experiencing LRTI, whether or not hospitalization was required. 25 In this study, the overall respiratory healthcare costs in all groups were relatively low. We did not, however, include the first year's costs in this study (these have been previously reported 7, 9 ) and it is in infancy the majority of hospitalizations occur, which are responsible for the majority of healthcare costs. We suggest, therefore, that the greatest burden associated with respiratory viral infections is encountered in the first year after birth.
The overall respiratory healthcare costs were significantly higher in those children who had had a viral LRTI not due to RSV or RV and this was associated with them having had significantly more respiratory related GP attendances, and significantly reduced FVC. The "other"
viruses included adenovirus, parainfluenza types 1 and 3, influenza A and human metapneumovirus. We have previously shown that human metapneumovirus is associated with elevated airways resistance at 1 year of age. 17 A number of the children in the RV group had experienced coinfection with other viruses. While the differences in healthcare costs between the RV and no LRTI groups did not reach statistical significance, they tended to be higher. It is possible therefore that coinfection with RV may influence outcome; larger studies with detailed multivariate analysis would be required to ascertain this. In both the RV and RSV groups compared to the no LRTI group, the non-respiratory medication costs were significantly higher, suggesting the children had other non-respiratory co- Furthermore, it has been suggested that study participation in paediatric populations decreases upon commencement of formal schooling. 28 Nevertheless, the children included in the current study were representative of the original cohort with regard to gestational age and birth weight.
In conclusion, in moderately prematurely born children, RV, and RSV LRTIs in infancy were not associated with significantly higher overall respiratory healthcare costs after infancy. Indeed, the respiratory healthcare costs in both groups were low with implications for the cost effectiveness of prophylactic agents in such a population.
Differences in pulmonary function were small and only detected using spirometry.
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